PinkDx Raises $40M in Series A Funding led by Catalio Capital Management, LP and The Production Board
PinkDx Raises $40M in Series A Funding led by Catalio Capital Management, LP and The Production Board
04/25/24, 7:02 PM
Location
daly cityMoney raised
$40 million
Industry
biotechnology
Round Type
series a
Investors
Mayo Clinic, Byers Capital, Mountain Group Partners, The Production Board, Catalio Capital Management, Lp
PinkDx, Inc., a Daly City, CA-based company, raised $40m in Series A financing. The round was co-led by Catalio Capital Management, LP, and The Production Board, with other investors including Mountain Group Partners, Byers Capital, and Mayo Clinic. The company will use the funds to test development, focusing initially on gynecological cancers.
Company Info
Location
2001 junipero serra blvd., suite 610
daly city, california, united states
Additional Info
PinkDx is an early-stage company focused on addressing the medical problems that women uniquely face by applying sophisticated scientific approaches to resolve them and providing answers that have an immediate, positive impact on their lives. The company's first indication will focus on overcoming diagnostic challenges for women who present with general symptoms that could signal a gynecological cancer.